HeartSciences (NASDAQ:HSCS – Get Free Report) and Mitesco (OTCMKTS:MITI – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends.
Institutional & Insider Ownership
17.2% of HeartSciences shares are owned by institutional investors. Comparatively, 0.0% of Mitesco shares are owned by institutional investors. 4.9% of HeartSciences shares are owned by company insiders. Comparatively, 4.9% of Mitesco shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of recent recommendations and price targets for HeartSciences and Mitesco, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| HeartSciences | 1 | 0 | 1 | 0 | 2.00 |
| Mitesco | 0 | 0 | 0 | 0 | 0.00 |
Volatility and Risk
HeartSciences has a beta of 2.44, suggesting that its stock price is 144% more volatile than the S&P 500. Comparatively, Mitesco has a beta of 5.6, suggesting that its stock price is 460% more volatile than the S&P 500.
Valuation & Earnings
This table compares HeartSciences and Mitesco”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| HeartSciences | N/A | N/A | -$8.77 million | ($4.94) | -0.41 |
| Mitesco | $40,000.00 | 47.83 | $500,000.00 | ($0.36) | -0.26 |
Mitesco has higher revenue and earnings than HeartSciences. HeartSciences is trading at a lower price-to-earnings ratio than Mitesco, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares HeartSciences and Mitesco’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| HeartSciences | N/A | -333.50% | -140.18% |
| Mitesco | -7,638.20% | -2.18% | 303.55% |
Summary
Mitesco beats HeartSciences on 7 of the 12 factors compared between the two stocks.
About HeartSciences
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
About Mitesco
Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.
Receive News & Ratings for HeartSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HeartSciences and related companies with MarketBeat.com's FREE daily email newsletter.
